Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate
2007-10-16
2010-02-02
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
C424S085400, C514S012200, C530S351000, C530S402000
Reexamination Certificate
active
07655223
ABSTRACT:
The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level. The present invention also includes antibodies to the Zcyto21 polypeptides, and methods of using the polynucleotides and polypeptides.
REFERENCES:
patent: 7135170 (2006-11-01), Klucher et al.
patent: 0 032 124 (1981-07-01), None
patent: 02/092762 (2002-11-01), None
patent: 03/066002 (2003-08-01), None
Vilcek et al. Novel Interferon. (2003), Nat. Immu. vol. 4 (1), pp. 8-9.
Adams et al., Accession No. T07139, 1993.
DOE Joint Genome Institute Stanford Human Genome Center, Accession No. AC011445, 1999.
Muzney et al., Accession No. AC0118477, 1999.
Sanger Centre Search Results, Accession No. AC011445, 2001.
University of California Santa Cruz database using Softberry, Inc. gene prediction software, Accession No. C19001084, 2001.
Scott et al., “The Pendred syndrome gene encodes a chloride-iodide transport protein,”Nature Genetics, 21:440-443, 1999.
Korba et al., “A cell culture assay for compounds which inhibit hepatitis B virus replication,”Antiviral Research 15:217-228, 1991.
Korba et al., “Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication,”Antiviral Research 19:55-70, 1992.
Kotenko et al., “IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex,”Nat. Immunol. 4(1):69-77, 2003.
Sheppard et al., “IL-28, IL-29 and their class II cytokine receptor IL-28R,”Nat. Immunol. 4(1):63-68, 2003.
Brack et al., “Molecular analysis of the human interferon-α gene family,”Gene 15:379-394, 1981.
Brady et al., U.S. Appl. No. 12/043,885, filed Mar. 6, 2008.
Klucher et al., U.S. Appl. No. 11/929,063, filed Oct. 30, 2007.
Fox Brian A.
Gilbert Teresa
Grant Francis J.
Haldeman Betty A.
Presnell Scott R.
Saoud Christine J
Seharaseyon Jegatheesan
Walsh Brian J.
ZymoGenetics, LLC
LandOfFree
Method of using interferon-like protein ZCYTO21 (IL-29) to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using interferon-like protein ZCYTO21 (IL-29) to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using interferon-like protein ZCYTO21 (IL-29) to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186945